Also trades as: NXG.V (TSXV) · $vol 0M
NEGXF OTC
NexgenRx Inc.
1W: -2.8%
1M: +37.5%
3M: +35.4%
YTD: +57.1%
1Y: +120.0%
3Y: +131.1%
5Y: +242.6%
$0.44
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$16M
+19.0% ▲
5Y CAGR: +11.5%
Gross Profit
$13M
+21.3% ▲
5Y CAGR: +11.8%
Operating Income
$1M
+932.2% ▲
Net Income
$615K
+285.1% ▲
EPS (Diluted)
$0.01
+206.4% ▲
EBITDA
$2M
+125.3% ▲
5Y CAGR: +19.6%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $10M | $12M | $12M | $14M | $16M |
| YoY Growth | +8.7% | +14.0% | +4.9% | +11.1% | +19.0% |
| Cost of Revenue | $2M | $3M | $4M | $3M | $3M |
| Gross Profit | $8M | $8M | $8M | $11M | $13M |
| Gross Margin | 77.7% | 71.5% | 68.2% | 78.1% | 79.6% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $7M | $6M | $8M | $1M | $1M |
| Operating Expenses | $7M | $6M | $8M | $11M | $12M |
| Operating Income | $2M | $2M | $79K | -$144K | $1M |
| Operating Margin | 14.5% | 18.2% | 0.6% | -1.0% | 7.3% |
| Interest Expense | $349K | $191K | $152K | $38K | $31K |
| Income Before Tax | $2M | $2M | $133K | -$305K | $1M |
| Tax Expense | -$306K | -$2M | $155K | $27K | $412K |
| Net Income | $2M | $4M | -$22K | -$332K | $615K |
| Net Margin | 20.4% | 34.1% | -0.2% | -2.4% | 3.7% |
| EPS (Diluted) | $0.03 | $0.05 | $-0.00 | $-0.00 | $0.01 |
| EBITDA | $2M | $4M | $2M | $1M | $2M |
| Shares Outstanding | 70M | 75M | 70M | 71M | 77M |